Changing paradigms in the management of differentiated thyroid cancer CPD Archived

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

Info

This video has been archived as it is more than 2 years old. CPD is no longer available.

x Mobile version: slides + audio only
-15s 00:00 / 20:23 +15s
Minimise video

Professor Mehanna speaks about the evolving guidelines and practices for the management of differentiated thyroid cancer. In particular Hisham looks at the changing paradigms surrounding incidence rate, personalisation of therapy, risk stratification and follow-up, and mortality. Hisham uses data from various clinical trials and publications to support his discussion.

This lecture was part of the 'thyroid (malignant)' event. It was held at The Royal Society of Medicine in London.

Date of lecture: 1st May 2015

This video is available for iPad via Safari 

Length: 00:20:23

Tips about RSM Videos

  • This video is free to view for RSM Members, please log in before watching. There is a fee of £6.00 for Non-Members.
  • The CPD process for this video has now expired. Previously booked CPD credits can still be accessed after login.
  • Click on the Slides tab to view all slides. You can make any slide larger by clicking on it.
  • Click on the Chapters tab to view different parts of the video.

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

53:49

Professor Nick Wareham, MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge

CPD Archived View
21:02

Dr Lisa Webber, Consultant Gynaecologist and Specialist in Reproductive Medicine, St Mary's Hospital.

CPD Archived View
27:37

Professor Julie Lovegrove, Deputy Director, Institute for Cardiovascular and Metabolic Research, University of Reading. 

CPD Archived View
29:11

Dr Nicola Bridges, Consultant Paediatric Endocrinologist, Chelsea & Westminster Hospital. 

CPD Archived View
13:43

Dr Breanne Everett, CEO and President, Orpyx, Calgary, Canada.

Free Archived View
29:37

Gordon Rustin, Director of Medical Oncology, East & North Hertfordshire NHS Trust. 

CPD Archived View
19:29

Robert Sherriff, National Operations Director, NHS Screening Programmes, Public Health England. 

Archived View
12:32

Lynne Lacey, Programme, Manager, NHS Diabetic Eye Screening Programme. 

Archived View
12:54

Madeline Johnson, Consultant in Public Health, Regional Quality Assurance Lead North, UK.

Archived View

Error

You must login to watch this lecture.